AR083828A1 - Formas cristalinas de un acido alcoxiimidazol-1-ilmetilfenil carboxilico - Google Patents

Formas cristalinas de un acido alcoxiimidazol-1-ilmetilfenil carboxilico

Info

Publication number
AR083828A1
AR083828A1 ARP110104201A ARP110104201A AR083828A1 AR 083828 A1 AR083828 A1 AR 083828A1 AR P110104201 A ARP110104201 A AR P110104201A AR P110104201 A ARP110104201 A AR P110104201A AR 083828 A1 AR083828 A1 AR 083828A1
Authority
AR
Argentina
Prior art keywords
crystalline
ilmetilfenil
alcoxiimidazol
acid
crystalline forms
Prior art date
Application number
ARP110104201A
Other languages
English (en)
Spanish (es)
Inventor
Paul A Fatheree
Venkat Thalladi
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of AR083828A1 publication Critical patent/AR083828A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP110104201A 2010-11-10 2011-11-10 Formas cristalinas de un acido alcoxiimidazol-1-ilmetilfenil carboxilico AR083828A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41201110P 2010-11-10 2010-11-10

Publications (1)

Publication Number Publication Date
AR083828A1 true AR083828A1 (es) 2013-03-27

Family

ID=45003086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104201A AR083828A1 (es) 2010-11-10 2011-11-10 Formas cristalinas de un acido alcoxiimidazol-1-ilmetilfenil carboxilico

Country Status (19)

Country Link
US (3) US8362060B2 (https=)
EP (1) EP2638017B1 (https=)
JP (2) JP2013542258A (https=)
KR (1) KR20130130730A (https=)
CN (1) CN103189362B (https=)
AR (1) AR083828A1 (https=)
AU (1) AU2011326622B2 (https=)
BR (1) BR112013011715A2 (https=)
CA (1) CA2812598A1 (https=)
CO (1) CO6741224A2 (https=)
ES (1) ES2567721T3 (https=)
IL (1) IL225303A0 (https=)
MX (1) MX2013005165A (https=)
NZ (1) NZ609804A (https=)
PH (1) PH12013500945A1 (https=)
RU (1) RU2013126403A (https=)
SG (1) SG189448A1 (https=)
TW (1) TW201300366A (https=)
WO (1) WO2012064807A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI448284B (zh) 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
CN106810542B (zh) * 2015-11-30 2021-03-09 苏州开拓药业股份有限公司 一种硫代咪唑烷酮化合物的晶型、盐型及其制备方法
EP4337638A1 (en) * 2021-05-11 2024-03-20 Astex Pharmaceuticals, Inc. Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027680A1 (en) 2004-09-10 2006-03-16 Pfizer Limited 3-(1-carbamoylcyclohexyl) propionic acid derivatives as inhibitors of neutral endopeptidase enzyme
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
WO2007106708A2 (en) 2006-03-10 2007-09-20 Novartis Ag Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
TW201014830A (en) * 2008-09-30 2010-04-16 Theravance Inc Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
TWI545114B (zh) * 2009-09-29 2016-08-11 施萬生物製藥研發Ｉｐ有限責任公司 製備聯苯基咪唑化合物之方法
US8399501B2 (en) 2010-03-04 2013-03-19 Theravance, Inc. Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof

Also Published As

Publication number Publication date
BR112013011715A2 (pt) 2017-10-31
CO6741224A2 (es) 2013-08-30
PH12013500945A1 (en) 2013-07-08
TW201300366A (zh) 2013-01-01
AU2011326622B2 (en) 2014-12-18
HK1187919A1 (zh) 2014-04-17
EP2638017B1 (en) 2016-01-27
RU2013126403A (ru) 2014-12-20
US20120115920A1 (en) 2012-05-10
JP2016028061A (ja) 2016-02-25
MX2013005165A (es) 2013-07-05
US9249105B2 (en) 2016-02-02
US8362060B2 (en) 2013-01-29
US20130267573A1 (en) 2013-10-10
KR20130130730A (ko) 2013-12-02
ES2567721T3 (es) 2016-04-26
JP2013542258A (ja) 2013-11-21
CN103189362A (zh) 2013-07-03
NZ609804A (en) 2015-02-27
CA2812598A1 (en) 2012-05-18
AU2011326622A1 (en) 2013-04-04
US20150133518A1 (en) 2015-05-14
IL225303A0 (en) 2013-06-27
WO2012064807A1 (en) 2012-05-18
US8802709B2 (en) 2014-08-12
CN103189362B (zh) 2015-03-11
EP2638017A1 (en) 2013-09-18
SG189448A1 (en) 2013-05-31

Similar Documents

Publication Publication Date Title
MX336810B (es) Benzoxazepinonas fusionadas como moduladoras de canales ionicos.
MX2020010330A (es) Proceso para preparar un compuesto antiviral de formula i.
MX2013014843A (es) Oxazepinas como moduladores del canal de iones.
MX2013012798A (es) Compuestos heterociclicos fusionados como moduladores del canal de sodio.
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
AR088018A1 (es) Proceso e intermediarios para preparar lapatinib
IN2015KN00262A (https=)
MY163394A (en) Substituted aminobutyric derivates as neprilysin inhibitors
MY165087A (en) Neprilysin inhibitors
EP2755955A4 (en) METHOD FOR PRODUCING SUBSTITUTED 3'-HYDRAZIN BIPHENYL-3-CARBOXYLIC ACID COMPOUNDS
EA201301181A1 (ru) Триазолопиридины
CR20140554A (es) Compuestos de acido dimetil-benzoico
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201391371A1 (ru) Фармацевтическая композиция ситаглиптина
EA201391265A1 (ru) Амиды индолкарбоновых и бензимидазолкарбоновых кислот в качестве инсектицидов и акарицидов
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
MX2015001374A (es) Compuestos.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX360048B (es) Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico.
MX362858B (es) Proceso para la preparacion de pemetrexed y sal de lisina del mismo.
AR073527A1 (es) Forma cristalina de un acido alcoxiimidazol-1-ilmetil bifenil carboxilico
IN2014MN01469A (https=)
CR20140325A (es) Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2-
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
ECSP13012548A (es) Inhibidores de oxadiazol de la producción de leucotrienos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure